Butterfly Needles Market Synopsis:
\nButterfly Needles Market Size Was Valued at USD 2.16 Billion in 2023, and is Projected to Reach USD 4.57 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032.
\nThis research will focus on the butterfly needles market which is the portion of the medical devices market that produces and sells butterfly needles; which are specific equipment used in blood drawing procedures. These needles are designed with a wing that provides more control and steadiness when inserted in the patient\u2019s vein; this type of needles is most appropriate where there is tough venous access. Butterfly needles are used widely in both hospital and community-care environments, especially in giving IV therapy to children and patients with small veins. Chronic diseases are Dow increasingly common, and the use of butterfly needles as an efficient and safe method to collect blood increases the demand in health care facilities.
\nButterfly needle is a fast-growing market due to factors such as growing prevalence of chronic diseases, an increasing elderly population, and enhancements in technology. New procedure such as Labiaplasty have driven patients to request for small incisions so Butterfly needles are preferred as they offer easy incisions and procedures. In addition, with modern trends focused on patient safety and comfort, new types of butterfly needles with safety guard have been designed to minimise the risk of needle stick injuries. This shift does not only improve the patient satisfaction but also meets the health departments and facilities for the safe standard regulations.
\nFurther, the growth of butterfly needle market is underlined by the rise in diagnostic test across the world. As more laboratories are working today than ever before \u2013 especially during the COVID-19 outbreak \u2013 there is an increased demand for blood collection devices. To meet this demand, manufacturers are developing and expanding on their product portfolios. The availability of new materials as well as designs intent on enhancing patients\u2019 wellbeing as well as increasing efficiency of the procedures is also influencing the stated market landscape. In conclusion, the butterfly needle market has promising outlook in the future as more and more healthcare organization look for efficient methods for the collection of blood samples.<\/p>\n
Butterfly Needles Market Trend Analysis:
\nIncreasing Adoption of Safety-Engineered Devices<\/p>\n
The butterfly needle market is experiencing the shift to safety-engineered butterfly needles. Due increasing concern about needlestick injuries and related risks, safety devices which help to reduce risks are focused now by today\u2019s care providers. Conventional butterfly needles modified into safety-engineered butterfly needles containing elements like retractable needle and safety shield are becoming popular. This change, however, is not solely induced by legal requirements but by the enhanced concern regarding the personnel\u2019s environment conditions in healthcare industries. Since health facilities will strive to meet the existing safety requirements, the need for such sophisticated instruments is expected to increase.<\/p>\n
In addition, many manufacturers have inventing butterfly needles which must be safe and easy to handle as well. Such advances include ergonomic features and easy to operate mechanisms that make the operating experience even better for the health care workers. Its application in these devices including smart tracking systems for proper disposal of needles in specific areas is also making them even more attractive. This trend towards safety-engineered solutions is likely to define the development of butterfly needle market in the years to come and contribute to safer healthcare environment.
\nExpansion in Emerging Markets<\/p>\n
The butterfly needle market should be invested in to expand the opportunity in emerging markets. Since many years, the healthcare industry is on the verge of growth in Asia-Pacific, Latin America, and Middle East countries, so there is a growing requirement of Butterfly Needles. Increasing incidences of chronic diseases and a growing population also serve to put pressure on better means of blood collection within these areas. Moreover, as more investments are made in the healthcare industry and as patients safety becomes further highlighted, there is an opportunity for the manufacturer to expand the market in these regions.
\nButterfly Needles Market Segment Analysis:
\nButterfly Needles Market is Segmented on the basis of Needle Length, Guage Size, End User, and Region
\nBy Needle Length, 5mm- 8mm segment is expected to dominate the market during the forecast period<\/p>\n
The butterfly needle market is expected to be dominated by the 5mm-8mm needle length segment during the forecast period because this needle length is suitable both for adults and children, and for patients with small veins. It is preferred due to the balance it offers of causing little patient discomfort while still offering efficient blood collection as compared to this segment. Rising utilization of minimally invasive surgeries in conjunction with the emphasis on the patient-centred approach creates the foundation for the butterfly needles demand within this length. In terms of application, venipuncture procedures are likely to remain a focus of high demand; thus, the 5mm-8mm segment will continue to dominate the market.
\nBy Guage Size, 21G-23G segment expected to held the largest share <\/p>\n
The gauge size of 21G-23G will dominate the butterfly needle market because this smaller gauge accommodates improved flexibility while being efficient in many clinical applications. Needles used in this gauge are preferred because of their adaptability to patients of different ages both adults and paediatric patients and the minimization of the pain when at of blood draw. Especially good for blood sampling and giving injections, this gauge size could be found in almost any hospital or outpatient clinic. Since caregivers insist on the efficiency of butterfly needles and their overall, security in the comfort of the patients, the forecasted demand for 21G-23G butterfly needles will still remain very promising to become a clinician\u2019s favourite.
\nButterfly Needles Market Regional Insights:
\nNorth America is Expected to Dominate the Market Over the Forecast period <\/p>\n
A market trend analysis showed that the butterfly needle market was led by North America, especially in 2023, and accounted for about 40% of the global market. Higher healthcare expenditure and an efficient healthcare sector has provided an environment, which has made the medical device industries such as butterfly needles to thrive. Among others, the United States ranks high in both technological and purchase of safety-engineered devices hence the large shares recorded on the global market. Moreover, the professional presence of key players and the strong regulation of pulling through innovations for medical devices remain a competitive advantage in the market of North America.<\/p>\n
Further, the changing demographic profile, rising emphasis on patient safety along with the escalating prevalence of chronic ailments has therefore continued to drive the demand for butterfly needles in North America. Since more medical facilities turn to more complex technologies for making procedures safer, this market may further expand in this region. For example, the focus on research and development within the regional market and the tendency towards increased popularity of outpatient treatments make North America one of the key segments of butterfly needle market.
\nActive Key Players in the Butterfly Needles Market <\/p>\n
AccuVein (United States)<\/p>\n
Ambu A\/S (Denmark)<\/p>\n
Amsino International (United States)<\/p>\n
Becton, Dickinson and Company (United States)<\/p>\n
Cardinal Health (United States)<\/p>\n
Coagula Medical (United States)<\/p>\n
Greiner Bio-One (Austria)<\/p>\n
Halyard Health (United States)<\/p>\n
Medline Industries (United States)<\/p>\n
Micrel Medical Devices (Greece)<\/p>\n
Nipro Corporation (Japan)<\/p>\n
Smiths Medical (United States)<\/p>\n
Stryker Corporation (United States)<\/p>\n
Terumo Corporation (Japan)<\/p>\n
Vygon (France)<\/p>\n
Other Active Players<\/p>\n","protected":false},"excerpt":{"rendered":"
This research will focus on the butterfly needles market which is the portion of the medical devices market that produces and sells butterfly needles; which are specific equipment used in blood drawing procedures. These needles are designed with a wing that provides more control and steadiness when inserted in the patient\u2019s vein; this type of needles is most appropriate where there is tough venous access. Butterfly needles are used widely in both hospital and community-care environments, especially in giving IV therapy to children and patients with small veins. Chronic diseases are Dow increasingly common, and the use of butterfly needles as an efficient and safe method to collect blood increases the demand in health care facilities.<\/p>\n","protected":false},"featured_media":23780,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-26589","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n